CN1219514C - 具有高吸收性的口服制剂 - Google Patents
具有高吸收性的口服制剂 Download PDFInfo
- Publication number
- CN1219514C CN1219514C CNB021439834A CN02143983A CN1219514C CN 1219514 C CN1219514 C CN 1219514C CN B021439834 A CNB021439834 A CN B021439834A CN 02143983 A CN02143983 A CN 02143983A CN 1219514 C CN1219514 C CN 1219514C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- agent
- bisbentiamine
- tocopherol
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP313977/2001 | 2001-10-11 | ||
| JP2001313977A JP2003119141A (ja) | 2001-10-11 | 2001-10-11 | 吸収性を向上した経口投与製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1411812A CN1411812A (zh) | 2003-04-23 |
| CN1219514C true CN1219514C (zh) | 2005-09-21 |
Family
ID=19132362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021439834A Expired - Fee Related CN1219514C (zh) | 2001-10-11 | 2002-09-29 | 具有高吸收性的口服制剂 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2003119141A (enExample) |
| KR (1) | KR20030030882A (enExample) |
| CN (1) | CN1219514C (enExample) |
| TW (1) | TWI244921B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4721631B2 (ja) * | 2003-09-30 | 2011-07-13 | 小林製薬株式会社 | 催眠剤組成物 |
| JP4780907B2 (ja) * | 2003-09-30 | 2011-09-28 | 小林製薬株式会社 | 催眠剤組成物 |
| JP5094899B2 (ja) * | 2010-03-23 | 2012-12-12 | 小林製薬株式会社 | 催眠剤組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61151132A (ja) * | 1984-12-24 | 1986-07-09 | Kanebo Ltd | ビタミンk↓2経口剤の製造法 |
| JPS63310827A (ja) * | 1987-06-15 | 1988-12-19 | Sanwa Kagaku Kenkyusho Co Ltd | ニコチン酸誘導体を主剤とする徐放性製剤 |
| JPH10130171A (ja) * | 1996-09-04 | 1998-05-19 | Dot:Kk | 経口投与用医薬組成物 |
| US6197328B1 (en) * | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
-
2001
- 2001-10-11 JP JP2001313977A patent/JP2003119141A/ja active Pending
-
2002
- 2002-09-05 TW TW091120354A patent/TWI244921B/zh not_active IP Right Cessation
- 2002-09-29 CN CNB021439834A patent/CN1219514C/zh not_active Expired - Fee Related
- 2002-10-07 KR KR1020020060903A patent/KR20030030882A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003119141A (ja) | 2003-04-23 |
| CN1411812A (zh) | 2003-04-23 |
| KR20030030882A (ko) | 2003-04-18 |
| TWI244921B (en) | 2005-12-11 |
| HK1054695A1 (en) | 2003-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004008222T2 (de) | Pflanzliche zusammensetzungen für prostataleiden | |
| CN101698028B (zh) | 一种降脂减肥组合物及其制备方法 | |
| US5324516A (en) | Galenic composition for decreasing blood alcohol concentration | |
| CA2551787C (en) | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent | |
| CN1899582A (zh) | 一种治疗慢性胃炎的药及其制备方法 | |
| CN112891399A (zh) | 一种中药组合物及其用途和制备方法 | |
| CN1435241A (zh) | 单味中药丸、片 | |
| CN101269205A (zh) | 一种调理气血、化瘀散结的药物组合及其制备方法 | |
| WO2005117895A2 (en) | Compositions comprising meloxicam | |
| JPH10298093A (ja) | 内用液剤 | |
| US20050142236A1 (en) | Composition comprising an aqueous extract of red vine leaves and a diuretic | |
| CN1219514C (zh) | 具有高吸收性的口服制剂 | |
| DE69330177T2 (de) | Zusammensetzung und Verfahren zur Verminderung des Hypotensionsrisikos | |
| CN111821256B (zh) | 一种自乳化乳霜基质及其用途 | |
| CN106474447A (zh) | 一种对抗头部感染,止痒防脱的组合物及其制备方法和应用 | |
| CN101564503A (zh) | 清眩治瘫丸制剂及其制备方法 | |
| JP2009242329A (ja) | 防風通聖散配合製剤 | |
| CN107115424B (zh) | 改变酸性体质保钙及清热解毒的中药组合物及制备方法 | |
| KR20030092519A (ko) | 알레르기성 피부질환의 개선 또는 예방용 조성물 | |
| CN1554390A (zh) | 一种治疗干燥综合症的中药制剂及其制备方法 | |
| Carradori et al. | Patent survey on saffron and its multiple applications: an update | |
| CN101336982A (zh) | 一种抑制脱发和/或促进头发再生的组合物 | |
| CN1341429A (zh) | 具有护肝和抗骨质疏松的保健食品 | |
| CN108295221B (zh) | 一种治疗帕金森病的中药组合物及其制备方法与应用 | |
| CN108815342A (zh) | 一种治疗男性不育的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050921 Termination date: 20100929 |